QL
BBIO icon

Quarry LP’s BridgeBio Pharma BBIO Stock Holding History

Quarry LP’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521K Buy
+7,001
New +$490K 0.04% 146
2026
Q1 		– Sell
-3,600
Closed -$275K – 1478
2025
Q4 		$275K Sell
3,600
-2,650
-42% -$174K 0.04% 229
2025
Q3 		$325K Sell
6,250
-5,750
-48% -$280K 0.07% 249
2025
Q2 		$518K Buy
12,000
+500
+4% +$18.2K 0.11% 156
2025
Q1 		$398K Buy
+11,500
New +$388K 0.09% 200
2024
Q4 		– Sell
-10,000
Closed -$255K – 1631
2024
Q3 		$255K Buy
10,000
+2,500
+33% +$65.6K 0.06% 198
2024
Q2 		$190K Buy
7,500
+1,600
+27% +$43.7K 0.05% 179
2024
Q1 		$182K Buy
5,900
+4,650
+372% +$158K 0.03% 190
2023
Q4 		$50.5K Buy
+1,250
New +$37.5K 0.01% 333

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Quarry LP's BBIO Position: Q2 2026 in Review

Quarry LP opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 7,001 shares worth $521K. The stake represents 0.04% of the portfolio and ranks #146 among its holdings. This is a return to the name: Quarry LP previously reported a position in BBIO as recently as Q4 2025.

Quarry LP first reported a position in BBIO in Q4 2023 and has held it in 9 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Quarry LP held 7,001 shares of BridgeBio Pharma worth $521K as of Q2 2026.
  • BridgeBio Pharma was a new Quarry LP position in Q2 2026.
  • BridgeBio Pharma made up 0.04% of Quarry LP's portfolio in Q2 2026, its #146 holding.
  • Quarry LP first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 9 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.